Login

• ..
• 110420 2BE-BEL----Referral Required from Authorizing Agency-IAAE.pdf
• 110504 2BE-BEL----Screening Required-IAAE.pdf
• 110512 2BE-BEL----11EN024 NIRB English Comment Form-IAAE.pdf
• 110512 2BE-BEL----11EN024 NIRB Inuktitut Comment Form-IAAS.pdf
• 110512 2BE-BEL----11EN024 Notice of Part 4 Screening and Comment Request-IAAE.pdf
• 110613 2BE-BEL----11EN024 Notice of Indication-IAAE.pdf
• 110613 2BE-BEL----11EN024 Screening Decision Report-IAAE.pdf
• 120221 2BE-BEL1114 11EN024-Referral Required from Authorizing Agency-OA1E.pdf
• 120323 2BE-BEL1114 11EN024-Comment Request Re Potential Exemption-OT6E.pdf
• 120404 2BE-BEL1114 NIRB 11EN024_ Public Comment Period Extended for Canadian Orebodies Inc-IMLE.pdf
• 120425 2BE-BEL1114 11EN024-Application Exempt Pursuant to NLCA 12 4 3-OT6E.pdf
• 120817 2BE-BEL1114 11EN024-Application Exempt Pursuant to NLCA 12 4 3-OT6E.pdf